Study says cheaper Avastin as good as Lucentis
Deborah Weinstein
May 02 2012
Genentech may have innovated itself into a corner. A study comparing its age-related macular degeneration drug, Lucentis, to its cancer ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.